OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEEâ„¢
[Business Wire] – OPKO Health, Inc. , has completed patient enrollment in the third phase 3 trial of RAYALDEE. This trial is designed to evaluate the product’s long-term safety and effica more
View todays social media effects on OPK
View the latest stocks trending across Twitter. Click to view dashboard